Clinical Trials Browser

Phase 2 × Neoplasms, Unknown Primary × Magnetic Resonance Spectroscopy × Clear all

NCT00119314 2015-05-27

Gemcitabine, Docetaxel, and Capecitabine in Treating Patients With Cancer of Unknown Primary Origin

Phase 2 Withdrawn

Neoplasms, Unknown Primary